BMO Capital lowered the firm's price target on Morningstar to $193 from $257 and keeps an Outperform rating on the shares. The company's Q4 results topped estimates, but Morningstar Direct Platform and PitchBook growth decelerated and the management noted some corrective actions in PitchBook given several headwinds the company is facing around competition, sales cycles, and AI strategy, the analyst tells investors in a research note.
